Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 100/100

Failure Rate

60.0%

3 terminated/withdrawn out of 5 trials

Success Rate

40.0%

-46.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 2
3(60.0%)
N/A
2(40.0%)
5Total
Phase 2(3)
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT02902822Not ApplicableCompleted

Tele-dermatology of Skin Cancer in a Cohort of Local Health Authority Employees in the Province of Bergamo

Role: lead

NCT01923142Phase 2Terminated

Efficacy of Autologous Outer-Root-Sheath Melanocytes Transplantation in the Treatment of Vitiligo

Role: lead

NCT01574872Phase 2Withdrawn

Efficacy of Aerosal® in the Treatment of Inverse Psoriasis and Sebopsoriasis

Role: collaborator

NCT01714284Not ApplicableCompleted

Efficacy Study of Dietary Intervention and Weight Loss in Improving Psoriasis

Role: lead

NCT01574885Phase 2Terminated

Efficacy of Aerosal® in the Treatment of Sub-Obstructive Adenotonsillar Hypertrophy and Related Diseases

Role: collaborator

All 5 trials loaded